Summary: Alkermes’ alixorexton met all primary and key secondary endpoints in a phase 2 trial for narcolepsy type 1, showing…
Tag: Clinical Trials
The Race Toward Orexin Agonists Targeting Narcolepsy’s Root Cause
By Alyx Arnett For the first time, investigational treatments for narcolepsy type 1 (NT1) are targeting the disorder’s root cause:…